hábit Labs · Devolve Corp
Certificate of Analysis
For research purposes only. This material is supplied for in-vitro laboratory research by qualified researchers. It shall not be used for human therapeutic purposes and is not for human or veterinary consumption. It is not a drug, supplement, cosmetic, food additive, or medical device.
Product identification
ProductACE-031 1mg
DescriptionActRIIB-Fc fusion protein
Lot numberACE-2606-A
Release dateJun 2026
Molecular formulaFc-fusion protein
AppearanceLyophilized powder
Storage−20 °C, protected from light
ManufacturerDevolve Corp d/b/a hábit · Ft. Lauderdale, FL
Analytical results
Identity (SDS-PAGE)Confirmed✓ Pass
Purity (SEC-HPLC)98.4%✓ Pass
Apparent MW≈78 kDa✓ Pass
Endotoxin (LAL)<1.0 EU/mg✓ Pass
AppearanceWhite cake✓ Pass
Identity by SDS-PAGE and anti-Fc Western blot, purity by SEC-HPLC (≥98%), endotoxin by LAL, appearance. As a recombinant fusion protein, ACE-031 is verified on a protein-specific assay panel. Third-party ISO-17025 verified.
Specifications
CompoundActRIIB-Fc fusion protein (ramatercept)
CAS1338449-44-3
Apparent MW (SDS-PAGE)≈78 kDa (homodimer)
ExpressionCHO-derived, glycosylated
FormLyophilized
Purity≥98% by SEC-HPLC
Endotoxin<1.0 EU/mg
Available dosages1mg
Lot prefixACE-
Storage & handling
Lyophilized: −20°C (−80°C for long-term), 24 months. Reconstitute with sterile water; for storage beyond 24 hours a carrier protein (e.g. 0.1% BSA) is recommended. Reconstituted: 2–8°C short-term; aliquot and avoid repeated freeze-thaw, which degrades fusion proteins.